| Literature DB >> 8126815 |
F E Govier1, E Jonsson, D Kramer-Levien.
Abstract
The widespread use of penile injections in the management of erectile dysfunction has led to an increased incidence of priapism. It has been suggested that terbutaline, a beta-agonist, might be beneficial in treating priapism in this setting. We randomized 24 patients with prolonged erections to a prospective, double-blind, placebo-controlled trial. We did not find any benefit of oral terbutaline over placebo in these patients.Entities:
Mesh：
Substances：
Year: 1994 PMID： 8126815 DOI： 10.1016/s0022-5347(17)35111-x
Source DB: PubMed Journal: J Urol ISSN： 0022-5347 Impact factor: 7.450